# The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients

> **NCT01762644** · PHASE3 · WITHDRAWN · sponsor: **Perle Bioscience, Inc.**

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Oral Cyclosporine and Oral Omeprazole
- **DRUG:** Oral Omeprazole

## Key facts

- **NCT ID:** NCT01762644
- **Lead sponsor:** Perle Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-08
- **Primary completion:** 2016-05
- **Final completion:** 2016-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was withdrawn prior to enrollment.
- **Last updated:** 2016-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01762644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01762644, "The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01762644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*